Hey, yes, I think that I pointed out that opioids is the hotspot right now and that MSBs rex has a great treatment for that hotspot, when I posted this article?
https://www.politico.com/news/2021/06/11/fda-woodcock-controversial-drug-approval-493324
Manchin's calling for Woodcocks removal, with the opioids as his hotspot outside of Aduhelm, too:
https://www.fiercepharma.com/pharma/sen-manchin-calls-for-woodcock-s-removal-as-fda-fallout-from-biogen-alzheimer-s-approval
To be sure, the Aduhelm approval isn’t the only issue the West Virginia senator has taken up with Woodcock. Manchin, along with six other Democrat and Independent senators, called on Biden earlier this year to institute new FDA leadership to address the ongoing opioid crisis. In Manchin’s Thursday letter, the senator said Woodcock has “shown a dereliction of duty by not working to end” the opioid epidemic.
Now, interestingly, the FDA just released its proposed 2022 budget, and its focussed squarely on the crisis (opioid not covid..):
https://www.fda.gov/news-events/fda-voices/fdas-budget-advancing-goal-ending-opioid-crisis
Of the below, I particularly liked 3, for some reason..Addressing Priority Areas and Developing New Treatments
As part of broad cross-government efforts, the FDA is committed to examining all facets of opioid abuse, misuse, addiction, overdose and death in the U.S. The agency is taking steps to address four priority areas to address the crisis: (1) decreasing exposure and preventing new addiction; (2) supporting the treatment of those with opioid use disorder (OUD); (3) fostering the development of novel non-opioid pain treatment therapies; and (4) improving enforcement and assessing benefit-risk.
What @What ?!
- Forums
- ASX - By Stock
- MSB
- Cell Therapy News/Articles
Cell Therapy News/Articles, page-9630
-
- There are more pages in this discussion • 8,633 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.51 |
Change
0.020(1.34%) |
Mkt cap ! $1.741B |
Open | High | Low | Value | Volume |
$1.57 | $1.58 | $1.41 | $18.15M | 12.09M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3418 | $1.50 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.51 | 24361 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 9994 | 1.505 |
4 | 32750 | 1.500 |
6 | 44085 | 1.495 |
7 | 91808 | 1.490 |
4 | 58451 | 1.485 |
Price($) | Vol. | No. |
---|---|---|
1.510 | 94676 | 9 |
1.515 | 71275 | 4 |
1.520 | 202127 | 7 |
1.525 | 59794 | 3 |
1.530 | 72259 | 4 |
Last trade - 16.10pm 07/10/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |